Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

RRECURSION PHARMACEUTICALS, INC.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
R

RECURSION PHARMACEUTICALS, INC.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $7.67M. Net result −$131.01M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $7.67M. Running result $7.67M. Grant: $367K. License And Service: $7.3M.
  • Cost of revenue: −$11.49M. Running result −$3.82M.
  • Gross loss: −$3.82M. Running result −$3.82M.
  • Research and development: −$89.61M. Running result −$93.44M.
  • General and administrative: −$41.53M. Running result −$134.97M.
  • Operating income: −$134.97M. Running result −$134.97M.
  • Other income: $3.96M. Running result −$131.01M.
  • Pre-tax loss: −$131.01M. Running result −$131.01M.
  • Income tax benefit: $1K. Running result −$131.01M.
  • Net loss: −$131.01M. Running result −$131.01M.